Patents by Inventor Ying-Hua CHANG

Ying-Hua CHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NATIVELY SUPPORTING JSON DUALITY VIEW IN A DATABASE MANAGEMENT SYSTEM
    Publication number: 20240126728
    Abstract: JSON Duality Views are object views that return JDV objects. JDV objects are virtual because they are not stored in a database as JSON objects. Rather, JDV objects are stored in shredded form across tables and table attributes (e.g. columns) and returned by a DBMS in response to database commands that request a JDV object from a JSON Duality View. Through JSON Duality Views, changes to the state of a JDV object may be specified at the level of a JDV object. JDV objects are updated in a database using optimistic lock.
    Type: Application
    Filed: October 14, 2022
    Publication date: April 18, 2024
    Inventors: ZHEN HUA LIU, JUAN R. LOAIZA, SUNDEEP ABRAHAM, SHUBHA BOSE, HUI JOE CHANG, SHASHANK GUGNANI, BEDA CHRISTOPH HAMMERSCHMIDT, TIRTHANKAR LAHIRI, YING LU, DOUGLAS JAMES MCMAHON, AUROSISH MISHRA, AJIT MYLAVARAPU, SUKHADA PENDSE, ANANTH RAGHAVAN
  • NATIVELY SUPPORTING JSON DUALITY VIEW IN A DATABASE MANAGEMENT SYSTEM
    Publication number: 20240126729
    Abstract: JSON Duality Views are object views that return JDV objects. JDV objects are virtual because they are not stored in a database as JSON objects. Rather, JDV objects are stored in shredded form across tables and table attributes (e.g. columns) and returned by a DBMS in response to database commands that request a JDV object from a JSON Duality View. Through JSON Duality Views, changes to the state of a JDV object may be specified at the level of a JDV object. JDV objects are updated in a database using optimistic lock.
    Type: Application
    Filed: October 14, 2022
    Publication date: April 18, 2024
    Inventors: ZHEN HUA LIU, JUAN R. LOAIZA, SUNDEEP ABRAHAM, SHUBHA BOSE, HUI JOE CHANG, SHASHANK GUGNANI, BEDA CHRISTOPH HAMMERSCHMIDT, TIRTHANKAR LAHIRI, YING LU, DOUGLAS JAMES MCMAHON, AUROSISH MISHRA, AJIT MYLAVARAPU, SUKHADA PENDSE, ANANTH RAGHAVAN
  • NATIVELY SUPPORTING JSON DUALITY VIEW IN A DATABASE MANAGEMENT SYSTEM
    Publication number: 20240126743
    Abstract: JSON Duality Views are object views that return JDV objects. JDV objects are virtual because they are not stored in a database as JSON objects. Rather, JDV objects are stored in shredded form across tables and table attributes (e.g. columns) and returned by a DBMS in response to database commands that request a JDV object from a JSON Duality View. Through JSON Duality Views, changes to the state of a JDV object may be specified at the level of a JDV object. JDV objects are updated in a database using optimistic lock.
    Type: Application
    Filed: October 14, 2022
    Publication date: April 18, 2024
    Inventors: ZHEN HUA LIU, JUAN R. LOAIZA, SUNDEEP ABRAHAM, SHUBHA BOSE, HUI JOE CHANG, SHASHANK GUGNANI, BEDA CHRISTOPH HAMMERSCHMIDT, TIRTHANKAR LAHIRI, YING LU, DOUGLAS JAMES MCMAHON, AUROSISH MISHRA, AJIT MYLAVARAPU, SUKHADA PENDSE, ANANTH RAGHAVAN
  • ROR1 BINDING PROTEIN AND USE THEREOF
    Publication number: 20240018237
    Abstract: The present invention relates to the field of treatment of diseases. Specifically, the present invention relates to an anti-ROR1 antibody or an antigen-binding fragment thereof, nucleic acid molecules for encoding same, and methods for preparing same. The anti-ROR1 antibody or the antigen-binding fragment thereof of the present invention has high specificity and high affinity for ROR1, and can effectively bind ROR1 and mediate killing of ROR1 expression cells. Therefore, the present invention further relates to a pharmaceutical composition comprising the antibody or antigen-binding fragment thereof, and a use thereof in preparation of a drug which is used for prevention and/or treatment of tumors.
    Type: Application
    Filed: February 28, 2022
    Publication date: January 18, 2024
    Applicants: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD., KLUS PHARMA INC.
    Inventors: Haijun TIAN, Yangde CHEN, Ying-Hua CHANG, Zhiqiang ZHU, Wenhui WU